Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

This study has been terminated.
(Administratively complete.)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00062387
First received: June 5, 2003
Last updated: May 31, 2013
Last verified: October 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Publications: